Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 57

Results For "NDA"

5510 News Found

Sanofi brings AI-driven rare disease diagnostic tool AccelRare to India
Digitisation | June 01, 2026

Sanofi brings AI-driven rare disease diagnostic tool AccelRare to India

Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device


Redcliffe Labs appoints Vijay T. S. as Chief People Officer
People | June 01, 2026

Redcliffe Labs appoints Vijay T. S. as Chief People Officer

Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments


Zydus’ Saroglitazar wins FDA priority review after strong Phase 3 results in liver disease trial
Drug Approval | June 01, 2026

Zydus’ Saroglitazar wins FDA priority review after strong Phase 3 results in liver disease trial

The therapy also delivered significant improvements in key liver enzyme markers


National Policy Dialogue adopts landmark 10-point declaration for people with disabilities
Healthcare | June 01, 2026

National Policy Dialogue adopts landmark 10-point declaration for people with disabilities

World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection


Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm
Opinion | June 01, 2026

Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm

We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms


Pfizer and Innovent Biologics strike $10 billion cancer drug deal
News | June 01, 2026

Pfizer and Innovent Biologics strike $10 billion cancer drug deal

This alliance, covering up to 12 antibody drugs, highlights the growing trend of large-scale collaborations between Chinese biotech firms and global pharmaceutical giants


FDA clears Cercare Medical’s CBCT perfusion technology for real-time stroke imaging
Medical Device | June 01, 2026

FDA clears Cercare Medical’s CBCT perfusion technology for real-time stroke imaging

The technology enables clinicians to assess brain tissue and microvascular reperfusion directly in the angiography suite, potentially improving stroke treatment decisions and patient outcomes


Clariant bags FDA nod for bio-based PVC additives
R&D | June 01, 2026

Clariant bags FDA nod for bio-based PVC additives

Derived from rice bran wax, Licocare RBW products offer a renewable solution with a substantially lower carbon footprint than conventional montan waxes


Pfizer’s BRAFTOVI combo doubles progression-free survival in aggressive colorectal cancer trial
Clinical Trials | June 01, 2026

Pfizer’s BRAFTOVI combo doubles progression-free survival in aggressive colorectal cancer trial

The results confirm the study’s primary endpoint of objective response rate and now deliver a striking signal in progression-free survival


Pfizer’s drug combo shows strong survival results in aggressive prostate cancer trial
Clinical Trials | June 01, 2026

Pfizer’s drug combo shows strong survival results in aggressive prostate cancer trial

This marks one of the most closely watched oncology readouts at this year’s medical congress